Clinical Trial Management System (CTMS) Market to Witness Expansion During 2021-2026

Stratview Research has published a new report titled “Clinical Trial Management System (CTMS) Market” which is segmented By Component (Software, Services), Delivery Mode (Cloud-based (SaaS) CTMS, Licensed Enterprise (On-premise) CTMS, Web-based (Hosted) CTMS), Type (Enterprise, Site), End User (Clinical Research Organizations (CROs), Medical Device Firms, Pharmaceutical & Biotechnology Firms, Other) and Region.

As per the study, the Clinical Trial Management System (CTMS) Market is expected to grow from USD 810.3 million in 2020 to USD 1597.5 million by 2026 at a CAGR of over 12.2% during the forecast period.

Report Highlights

This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.

The market is bifurcated into various segments. Below given is the segment-wise analysis -

Based on end users, the market has been segmented into clinical research organizations (CROS), medical device firms, pharmaceutical & biotechnology firms, and others. The clinical research organizations segment accounted for the largest market share in 2020 and is projected to register significant CAGR during the review period.

Geographically, the market in North America accounted for the largest market share in 2020 and is expected to register significant CAGR during the review period. The market growth can be attributed to the high demand for advanced IT solutions in the healthcare sector coupled with the presence of key market players such as ArisGlobal LLC (US) and Bioclinica (US). The market in Asia-Pacific is expected to be driven by the rising adoption of CTMS in developing countries, particularly China and India.

Who are the Key Players in the Market?

This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Clinical Trial Management System (CTMS) Market:

• ArisGlobal LLC (US)
• Bioclinica (US)
• Bio-Optronics (US)
• DataTrak International, Inc. (US)
• Document Solutions Group (US)
• Eclinforce Inc (US)
• Advarra, Inc. (US)
• Medidata Solutions (US)
• MedNet Solutions, Inc. (US)
• Oracle Corporation (US)
• Parexel International (US)
• Veeva Systems Inc. (US)

Request a sample here- https://www.stratviewresearch.com/Request-Sample/2407/Clinical-Trial-Management-System-(CTMS)-Market.html#form

Custom Research:

Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.

Article source: https://article-realm.com/article/Finance/33237-Clinical-Trial-Management-System-CTMS-Market-to-Witness-Expansion-During-2021-2026.html